Dick Menzies

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

Timothy R. Sterling, Margarita E. Villarino, Andrey Borisov et al. · New England Journal of Medicine · 2011 · 983 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis

Daphne Yee, Chantal Valiquette, Marthe Pelletier et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 841 citations

Medicine, Pharmacology, Pharmacotherapy +15

False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?

Maha Farhat, Christina Greenaway, Madhukar Pai et al. · PubMed · 2006 · 642 citations

Public Health, Immunology, Infectious Diseases +17

The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices

Alice Zwerling, Marcel A. Behr, Aman Verma et al. · PLoS Medicine · 2011 · 594 citations · Full text

Public Affairs, Health Policy, Preventive Medicine +12

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

Payam Nahid, Sundari Mase, Giovanni Battista Migliori et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 453 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17